3D Breast Cancer Specimen Imaging The Future is Now
Summary
According to Vikram Butani, CEO of Kubtec, “3D specimen imaging is truly a game changer, as for the first time surgeons and radiologists will be able to clearly visualize the tumor and spiculations and not just the fiducials placed by the physician prior to the surgery based on the mammogram.In an effort to foster breast conservation and avoid the scarring and suffering that accompany mastectomies and re-excisions, 3D specimen imaging enables doctors to get it right the first time and allows patients to have greater confidence in their standard of care.Fine details are more visible and are less likely to be hidden by overlapping tissue.” This breakthrough in intraoperative breast cancer technology has yet to be fully embraced by the medical community, either out of unawareness of its existence or reliance on legacy 2D equipment for familiarity reasons.About Kubtec® Kubtec, a registered trademark of KUB Technologies, Inc., develops and manufactures digital X-ray systems for clinical and non-clinical applications, including low-dose neonatal imaging, specimen radiography, scientific research, forensic analysis, non-destructive testing, irradiation and more.Fine details are more visible and are less likely to be hidden by overlapping tissue.”This breakthrough in intraoperative breast cancer technology has yet to be fully embraced by the medical community, either out of unawareness of its existence or reliance on legacy 2D equipment for familiarity reasons.